Skip Nav Destination
Issues
1 May 2016
-
Cover Image
Cover Image
Individuals harboring inherited heterozygous mutations of the BAP1 gene are predisposed to a spectrum of neoplasms, including malignant mesothelioma. Using genetically engineered mouse models, it was found that inactivating germline Bap1 mutations behave as potent cancer susceptibility alleles, giving rise to a variety of malignant tumor types, including occasional mesotheliomas. However, high penetrance of mesothelioma in Bap1-mutant mice required exposure to asbestos. The image depicts hematoxylin and eosin staining of a spontaneous malignant mesothelioma invading the pancreas of mouse with a germline Bap1 mutation. For details, see article by Kadariya and colleagues on page 2836. - PDF Icon PDF LinkTable of Contents
ISSN 0008-5472
EISSN 1538-7445
Journal Archive
Cancer Research (1941-Present; volumes 1-current)
(ISSN 0008-5472) Published twice monthly since 1987. From 1941-1986, published monthly.The American Journal of Cancer (1931-1940; volumes 15-40)
(ISSN 0099-7374) Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.The Journal of Cancer Research (1916-1930); volumes 1-14)
(ISSN 0099-7013) Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.Table of Contents
Breaking Advances
Cancer Research 75th Anniversary Commentaries
Reviews
Integrated Systems and Technologies
Microenvironment and Immunology
TGFβ Signaling in the Pancreatic Tumor Microenvironment Promotes Fibrosis and Immune Evasion to Facilitate Tumorigenesis
Daniel R. Principe; Brian DeCant; Emman Mascariñas; Elizabeth A. Wayne; Andrew M. Diaz; Naomi Akagi; Rosa Hwang; Boris Pasche; David W. Dawson; Deyu Fang; David J. Bentrem; Hidayatullah G. Munshi; Barbara Jung; Paul J. Grippo
Author Choice
Feasibility of Telomerase-Specific Adoptive T-cell Therapy for B-cell Chronic Lymphocytic Leukemia and Solid Malignancies
Sara Sandri; Sara Bobisse; Kelly Moxley; Alessia Lamolinara; Francesco De Sanctis; Federico Boschi; Andrea Sbarbati; Giulio Fracasso; Giovanna Ferrarini; Rudi W. Hendriks; Chiara Cavallini; Maria Teresa Scupoli; Silvia Sartoris; Manuela Iezzi; Michael I. Nishimura; Vincenzo Bronte; Stefano Ugel
CSF1 Overexpression Promotes High-Grade Glioma Formation without Impacting the Polarization Status of Glioma-Associated Microglia and Macrophages
Ishani De; Megan D. Steffen; Paul A. Clark; Clayton J. Patros; Emily Sokn; Stephanie M. Bishop; Suzanne Litscher; Vilena I. Maklakova; John S. Kuo; Fausto J. Rodriguez; Lara S. Collier
IL15 Agonists Overcome the Immunosuppressive Effects of MEK Inhibitors
Michael J. Allegrezza; Melanie R. Rutkowski; Tom L. Stephen; Nikolaos Svoronos; Amelia J. Tesone; Alfredo Perales-Puchalt; Jenny M. Nguyen; Fahmida Sarmin; Mee R. Sheen; Emily K. Jeng; Julia Tchou; Hing C. Wong; Steven N. Fiering; Jose R. Conejo-Garcia
Author Choice
Stromal-Based Signatures for the Classification of Gastric Cancer
Mark T. Uhlik; Jiangang Liu; Beverly L. Falcon; Seema Iyer; Julie Stewart; Hilal Celikkaya; Marguerita O'Mahony; Christopher Sevinsky; Christina Lowes; Larry Douglass; Cynthia Jeffries; Diane Bodenmiller; Sudhakar Chintharlapalli; Anthony Fischl; Damien Gerald; Qi Xue; Jee-yun Lee; Alberto Santamaria-Pang; Yousef Al-Kofahi; Yunxia Sui; Keyur Desai; Thompson Doman; Amit Aggarwal; Julia H. Carter; Bronislaw Pytowski; Shou-ching Jaminet; Fiona Ginty; Aejaz Nasir; Janice A. Nagy; Harold F. Dvorak; Laura E. Benjamin
Molecular and Cellular Pathobiology
The Prosurvival IKK-Related Kinase IKKϵ Integrates LPS and IL17A Signaling Cascades to Promote Wnt-Dependent Tumor Development in the Intestine
Serkan Ismail Göktuna; Kateryna Shostak; Tieu-Lan Chau; Lukas C. Heukamp; Benoit Hennuy; Hong-Quan Duong; Aurélie Ladang; Pierre Close; Iva Klevernic; Fabrice Olivier; Alexandra Florin; Grégory Ehx; Frédéric Baron; Maud Vandereyken; Souad Rahmouni; Lars Vereecke; Geert van Loo; Reinhard Büttner; Florian R. Greten; Alain Chariot
Genomic Loss of DUSP4 Contributes to the Progression of Intraepithelial Neoplasm of Pancreas to Invasive Carcinoma
Naoki Hijiya; Yoshiyuki Tsukamoto; Chisato Nakada; Lam Tung Nguyen; Tomoki Kai; Keiko Matsuura; Kohei Shibata; Masafumi Inomata; Tomohisa Uchida; Akinori Tokunaga; Kohei Amada; Kuniaki Shirao; Yasunari Yamada; Hiromu Mori; Ichiro Takeuchi; Masao Seto; Masahiro Aoki; Mutsuhiro Takekawa; Masatsugu Moriyama
Author Choice
The Ribonucleic Complex HuR-MALAT1 Represses CD133 Expression and Suppresses Epithelial–Mesenchymal Transition in Breast Cancer
Elisa Latorre; Stephana Carelli; Ivan Raimondi; Vito D'Agostino; Ilaria Castiglioni; Chiara Zucal; Giacomina Moro; Andrea Luciani; Giorgio Ghilardi; Eleonora Monti; Alberto Inga; Anna Maria Di Giulio; Alfredo Gorio; Alessandro Provenzani
An Epigenetic Reprogramming Strategy to Resensitize Radioresistant Prostate Cancer Cells
Claudia Peitzsch; Monica Cojoc; Linda Hein; Ina Kurth; Katrin Mäbert; Franziska Trautmann; Barbara Klink; Evelin Schröck; Manfred P. Wirth; Mechthild Krause; Eduard A. Stakhovsky; Gennady D. Telegeev; Vladimir Novotny; Marieta Toma; Michael Muders; Gustavo B. Baretton; Fiona M. Frame; Norman J. Maitland; Michael Baumann; Anna Dubrovska
Rab11-FIP1C Is a Critical Negative Regulator in ErbB2-Mediated Mammary Tumor Progression
Pierre-Luc Boulay; Louise Mitchell; Jason Turpin; Julie-Émilie Huot-Marchand; Cynthia Lavoie; Virginie Sanguin-Gendreau; Laura Jones; Shreya Mitra; Julie M. Livingstone; Shirley Campbell; Michael Hallett; Gordon B. Mills; Morag Park; Lewis Chodosh; Douglas Strathdee; Jim C. Norman; William J. Muller
Therapeutics, Targets, and Chemical Biology
CRM1 Inhibition Promotes Cytotoxicity in Ewing Sarcoma Cells by Repressing EWS-FLI1–Dependent IGF-1 Signaling
Haibo Sun; De-Chen Lin; Qi Cao; Xiao Guo; Helene Marijon; Zhiqiang Zhao; Sigal Gery; Liang Xu; Henry Yang; Brendan Pang; Victor Kwan Min Lee; Huey Jin Lim; Ngan Doan; Jonathan W. Said; Peiguo Chu; Anand Mayakonda; Tom Thomas; Charles Forscher; Erkan Baloglu; Sharon Shacham; Raja Rajalingam; H. Phillip Koeffler
Natural Product Vibsanin A Induces Differentiation of Myeloid Leukemia Cells through PKC Activation
Zu-Yin Yu; He Xiao; Li-Mei Wang; Xing Shen; Yu Jing; Lin Wang; Wen-Feng Sun; Yan-Feng Zhang; Yu Cui; Ya-Jun Shan; Wen-Bing Zhou; Shuang Xing; Guo-Lin Xiong; Xiao-Lan Liu; Bo Dong; Jian-Nan Feng; Li-Sheng Wang; Qing-Liang Luo; Qin-Shi Zhao; Yu-Wen Cong
Author Choice
Intracellular Released Payload Influences Potency and Bystander-Killing Effects of Antibody-Drug Conjugates in Preclinical Models
Fu Li; Kim K. Emmerton; Mechthild Jonas; Xinqun Zhang; Jamie B. Miyamoto; Jocelyn R. Setter; Nicole D. Nicholas; Nicole M. Okeley; Robert P. Lyon; Dennis R. Benjamin; Che-Leung Law
HSP70 Inhibition Limits FAK-Dependent Invasion and Enhances the Response to Melanoma Treatment with BRAF Inhibitors
Anna Budina-Kolomets; Marie R. Webster; Julia I-Ju Leu; Matthew Jennis; Clemens Krepler; Anastasia Guerrini; Andrew V. Kossenkov; Wei Xu; Giorgos Karakousis; Lynn Schuchter; Ravi K. Amaravadi; Hong Wu; Xiangfan Yin; Qin Liu; Yiling Lu; Gordon B. Mills; Xiaowei Xu; Donna L. George; Ashani T. Weeraratna; Maureen E. Murphy
Author Choice
Second-Generation HSP90 Inhibitor Onalespib Blocks mRNA Splicing of Androgen Receptor Variant 7 in Prostate Cancer Cells
Roberta Ferraldeschi; Jonathan Welti; Marissa V. Powers; Wei Yuan; Tomoko Smyth; George Seed; Ruth Riisnaes; Somaieh Hedayat; Hannah Wang; Mateus Crespo; Daniel Nava Rodrigues; Ines Figueiredo; Susana Miranda; Suzanne Carreira; John F. Lyons; Swee Sharp; Stephen R. Plymate; Gerhardt Attard; Nicola Wallis; Paul Workman; Johann S. de Bono
Quantitative Phosphotyrosine Profiling of Patient-Derived Xenografts Identifies Therapeutic Targets in Pediatric Leukemia
Sibasish Dolai; Keith C.S. Sia; Alissa K. Robbins; Ling Zhong; Sue L. Heatley; Tiffaney L. Vincent; Falko Hochgräfe; Rosemary Sutton; Raushan T. Kurmasheva; Tamas Revesz; Deborah L. White; Peter J. Houghton; Malcolm A. Smith; David T. Teachey; Roger J. Daly; Mark J. Raftery; Richard B. Lock
The BRCA1-Δ11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and Cisplatin
Yifan Wang; Andrea J. Bernhardy; Cristina Cruz; John J. Krais; Joseph Nacson; Emmanuelle Nicolas; Suraj Peri; Hanneke van der Gulden; Ingrid van der Heijden; Shane W. O'Brien; Yong Zhang; Maribel I. Harrell; Shawn F. Johnson; Francisco J. Candido Dos Reis; Paul D. P. Pharoah; Beth Karlan; Charlie Gourley; Diether Lambrechts; Georgia Chenevix-Trench; Håkan Olsson; Javier J. Benitez; Mark H. Greene; Martin Gore; Robert Nussbaum; Siegal Sadetzki; Simon A. Gayther; Susanne K. Kjaer; kConFab Investigators; Alan D. D'Andrea; Geoffrey I. Shapiro; David L. Wiest; Denise C. Connolly; Mary B. Daly; Elizabeth M. Swisher; Peter Bouwman; Jos Jonkers; Judith Balmaña; Violeta Serra; Neil Johnson
Tumor and Stem Cell Biology
Corrections
Advertisement